IPF clinical trial design and endpoints

PURPOSE OF REVIEW: There remains a dire need for therapies that impact the clinical course of patients with idiopathic pulmonary fibrosis (IPF). Indeed, there is a surge of interest in IPF therapeutics, with many candidate agents in various stages of development. Optimal design and implementation of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nathan, Steven D., Meyer, Keith C.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
INTERSTITIAL LUNG DISEASE: Edited by Francesco Bonella and Steven D. Nathan
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4162322/
https://ncbi.nlm.nih.gov/pubmed/25022315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCP.0000000000000091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados